Business Wire: Uvax Bio Receives Approval to Initiate a Phase 1 Clinical Trial of Novel HIV-1 Protein Nanoparticle Vaccine Candidates in Australia
Uvax Bio Receives Approval to Initiate a Phase 1 Clinical Trial of Novel HIV-1 Protein Nanoparticle Vaccine Candidates in Australia
Nasdaq: Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial ...
Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial ...
Business Wire: MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent
MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent
Healio: FDA clears way for trial of novel bispecific T-cell engager for lupus
FDA clears way for trial of novel bispecific T-cell engager for lupus
Morningstar: Mabwell Announces First-Patient Dosed in Clinical Trial of Novel CDH17-Targeting ADC 7MW4911 in the U.S.
Mabwell Announces First-Patient Dosed in Clinical Trial of Novel CDH17-Targeting ADC 7MW4911 in the U.S.
Medical Xpress on MSN: Global trial shows novel treatment for triple-negative breast cancer nearly doubles survival
Global trial shows novel treatment for triple-negative breast cancer nearly doubles survival
News-Medical.Net: Trial shows safety of novel KIR-CAR T therapy in solid tumors
Nasdaq: Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine
Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine
Nasdaq: Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers
Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers